Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pim J French

Showing results (41-50 of 124) with videos related to

Pageof 13
Sort By:
Plos One|July 16, 2011
Absence of common somatic alterations in genes on 1p and 19q in oligodendrogliomasLinda B Bralten, Stephan Nouwens, Christel Kockx, et al.
The Journal of Biological Chemistry|January 31, 2004
Differential amplification of intron-containing transcripts reveals long term potentiation-associated up-regulation of specific Pde10A phosphodiesterase splice variantsVincent O'Connor, Alexis Genin, Sabrina Davis, et al.
Neuro-Oncology Advances|March 27, 2026
Delta-like ligand 3 expression in isocitrate dehydrogenase-mutant and isocitrate dehydrogenase-wildtype glioma is largely retained at recurrence, supporting its potential as a therapeutic targetRosa Luning, Sybren L N Maas, Pim J French, et al.
Free Neuropathology|May 8, 2024
Malignant glioma in L-2-Hydroxyglutaric Aciduria: thorough molecular characterization of a case and literature reviewFleur Cordier, Pieter Wesseling, Bastiaan B J Tops, et al.
Plos One|August 9, 2008
Exon expression arrays as a tool to identify new cancer genesMieke Schutte, Fons Elstrodt, Linda B C Bralten, et al.
Neuro-Oncology|September 11, 2015
Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trialHendrikus J Dubbink, Peggy N Atmodimedjo, Johan M Kros, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2014
A glioma classification scheme based on coexpression modules of EGFR and PDGFRAYingyu Sun, Wei Zhang, Dongfeng Chen, et al.
Genes, Chromosomes & Cancer|March 3, 2010
Integrated genomic profiling identifies candidate genes implicated in glioma-genesis and a novel LEO1-SLC12A1 fusion geneLinda B C Bralten, Nanne K Kloosterhof, Lonneke A M Gravendeel, et al.
Journal of Neuro-Oncology|April 18, 2018
Prognostic relevance of mutations and copy number alterations assessed with targeted next generation sequencing in IDH mutant grade II gliomaMaarten M J Wijnenga, Pim J French, Hendrikus J Dubbink, et al.
Cancer Research|December 17, 2005
Gene expression profiles associated with treatment response in oligodendrogliomasPim J French, Sigrid M A Swagemakers, Jord H A Nagel, et al.
Pageof 13

Showing results (41-50 of 124) with videos related to

Sort By:
Pageof 13
Plos One|July 16, 2011
Absence of common somatic alterations in genes on 1p and 19q in oligodendrogliomasLinda B Bralten, Stephan Nouwens, Christel Kockx, et al.
The Journal of Biological Chemistry|January 31, 2004
Differential amplification of intron-containing transcripts reveals long term potentiation-associated up-regulation of specific Pde10A phosphodiesterase splice variantsVincent O'Connor, Alexis Genin, Sabrina Davis, et al.
Neuro-Oncology Advances|March 27, 2026
Delta-like ligand 3 expression in isocitrate dehydrogenase-mutant and isocitrate dehydrogenase-wildtype glioma is largely retained at recurrence, supporting its potential as a therapeutic targetRosa Luning, Sybren L N Maas, Pim J French, et al.
Free Neuropathology|May 8, 2024
Malignant glioma in L-2-Hydroxyglutaric Aciduria: thorough molecular characterization of a case and literature reviewFleur Cordier, Pieter Wesseling, Bastiaan B J Tops, et al.
Plos One|August 9, 2008
Exon expression arrays as a tool to identify new cancer genesMieke Schutte, Fons Elstrodt, Linda B C Bralten, et al.
Neuro-Oncology|September 11, 2015
Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trialHendrikus J Dubbink, Peggy N Atmodimedjo, Johan M Kros, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2014
A glioma classification scheme based on coexpression modules of EGFR and PDGFRAYingyu Sun, Wei Zhang, Dongfeng Chen, et al.
Genes, Chromosomes & Cancer|March 3, 2010
Integrated genomic profiling identifies candidate genes implicated in glioma-genesis and a novel LEO1-SLC12A1 fusion geneLinda B C Bralten, Nanne K Kloosterhof, Lonneke A M Gravendeel, et al.
Journal of Neuro-Oncology|April 18, 2018
Prognostic relevance of mutations and copy number alterations assessed with targeted next generation sequencing in IDH mutant grade II gliomaMaarten M J Wijnenga, Pim J French, Hendrikus J Dubbink, et al.
Cancer Research|December 17, 2005
Gene expression profiles associated with treatment response in oligodendrogliomasPim J French, Sigrid M A Swagemakers, Jord H A Nagel, et al.
Pageof 13